# Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion

> **NCT04965038** · PHASE3 · TERMINATED · sponsor: **University Hospital Tuebingen** · enrollment: 127 (actual)

## Conditions studied

- Central Retinal Artery Occlusion

## Interventions

- **DRUG:** Tenecteplase (until trial protocol V04: Alteplase)

## Key facts

- **NCT ID:** NCT04965038
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-10-10
- **Primary completion:** 2026-03-23
- **Final completion:** 2026-04-29
- **Target enrollment:** 127 (ACTUAL)
- **Why stopped:** Stopped after prespecified interim analysis due to futility
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04965038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04965038, "Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT04965038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*